ロード中...
Hepatocellular Toxicity Associated with Tyrosine Kinase Inhibitors: Mitochondrial Damage and Inhibition of Glycolysis
Tyrosine kinase inhibitors (TKIs) are anticancer drugs with a lesser toxicity than classical chemotherapeutic agents but still with a narrow therapeutic window. While hepatotoxicity is known for most TKIs, underlying mechanisms remain mostly unclear. We therefore aimed at investigating mechanisms of...
保存先:
| 出版年: | Front Pharmacol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5469902/ https://ncbi.nlm.nih.gov/pubmed/28659801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00367 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|